comparemela.com

Latest Breaking News On - Swedish orphan biovitrum ab - Page 5 : comparemela.com

The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company s commitments under the incentive programme

/PRNewswire/ The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 9 May 2023, resolved – for the purpose of ensuring that the company.

United statesSobi investor relations teamManagement programmeAnnual general meetingSwedish orphan biovitrumNorth americaMiddle eastSobi mediaOrphan biovitrumSwedish orphan biovitrum ab

EMA validates marketing authorisation application for efanesoctocog alfa for treatment of haemophilia A

/PRNewswire/ Sobi today announced that the European Medicines Agency (EMA) has accepted and validated a marketing authorisation application for.

United statesPrnewswire sobiTony hoosHead of research developmentSobi investor relations teamEuropean medicines agencyDrug administrationChief medicalNorth africaMiddle easternNorth americaMiddle eastSobi mediaOrphan biovitrumSwedish orphan biovitrum abMedical pharmaceuticals

Sobi to acquire CTI BioPharma Corp enhancing Sobi s position in rare haematology

/PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) today announced that it has entered into an agreement and plan of merger with CTI.

United statesUnited kingdomCamilla sandstrGuido oelkersAmerica europeMannheimer swartlingDanske bankAmerica corporationBiopharma corpLatham watkinsCleopatra acquisition corpExchange commissionSobi investor relations teamSwedish orphan biovitrumGuido oelkers presidentHart scott rodino antitrust improvements

Bulletin from Swedish Orphan Biovitrum (Sobi) s Annual General Meeting (AGM)

/PRNewswire/ The Sobi® AGM was convened today on 9 May 2023. At the AGM, the shareholders, in accordance with the proposed resolutions, resolved as follows:.

United statesBo jesper hansenHelena saxonChristophe bourdonBiovitrum sobiAnders ullmanAnnette clancyFilippa stenbergSobi investor relations teamEmployee programmeManagement programmeNomination committeeJesper hansenAll employee programmeMall employeeNorth america

Sobi publishes Q1 2023 report: Continued solid progress

/PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter of 2023 First quarter 2023 Total revenue SEK 5,239.

United statesUnited kingdomCamilla sandstrSobi investor relations teamSwedish orphan biovitrumAlternative performanceNorth americaMiddle eastSobi mediaExternal communicationOrphan biovitrumSwedish orphan biovitrum ab

vimarsana © 2020. All Rights Reserved.